dr. james l. gulley on treatment beyond the second line in bladder cancer
Published 8 years ago • 84 plays • Length 1:30Download video MP4
Download video MP3
Similar videos
-
1:08
dr. james l. gulley on atezolizumab, pembrolizumab, and avelumab's potential uses in bladder cancer
-
1:06
dr. gulley on checkpoint inhibitors in bladder cancer
-
54:14
emerging concepts in prostate cancer immunotherapy with james l. gulley and ravi a. madan
-
5:06
state of the art research in bladder cancer treatment
-
15:31
bladder cancer guide
-
32:30
bladder cancer and immunotherapy with dr. terence friedlander
-
20:08
ask us anything about... bladder cancer - penn state cancer institute
-
2:29
bladder cancer treatment updates by prof. jones
-
2:41
johns hopkins greenberg bladder cancer institute
-
54:20
advances in the treatment of metastatic bladder cancer
-
1:20
dr. galsky on the role of ipilimumab for the treatment of bladder cancer
-
21:59
treatment talk | what are germline mutations in bladder cancer?
-
1:53
discussing recent advances and clinical trials in bladder cancer
-
22:27
2021 west oncology | genitourinary cancers | latest updates on advanced bladder cancer
-
1:09
keynote-045 – pembrolizumab as second-line treatment in urothelial carcinoma
-
1:18
preview: advances in bladder cancer treatment
-
4:00
how is bladder cancer diagnosed and treated?
-
1:47
the future of bladder cancer | johns hopkins greenberg bladder cancer institute
-
2:06
a golden age for bladder cancer publications
-
1:18
preview: advances in bladder cancer treatment
-
2:00
three decades of bladder cancer treatment
-
1:09
dr. galsky on the role of ipilimumab in bladder cancer